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Abstract
Transcription factors GATA-4, -5, and -6 constitute an evolutionary conserved subfamily of vertebrate zinc finger regulators highly
expressed in the developing heart and gut. Genetic evidence suggests that each protein is essential for embryonic development, but their
exact functions are not fully elucidated. Moreover, because all three proteins share similar transcriptional properties in vitro, and because
transcripts for two or more GATA genes are present in similar tissues, the molecular basis underlying in vivo specificity of GATA factors
remains undefined. Knowledge of the exact cell types expressing each protein and identification of downstream targets would greatly help
define their function. We have used high-resolution immunohistochemistry to precisely determine the cellular distribution of the GATA-4,
-5, and -6 proteins in murine embryogenesis. The results reveal novel sites of expression in mesodermal and ectodermal cells. In particular,
GATA-4 and -6 expression was closely associated with yolk sac vasculogenesis and early endoderm–mesoderm signaling. Additionally,
GATA-6 was strongly expressed in the embryonic ectoderm, neural tube, and neural crest-derived cells. This pattern of expression closely
paralled that of BMP-4, and the BMP-4 gene was identified as a direct downstream target for GATA-4 and -6. These findings offer new
insight into the function of GATA-4 and -6 during early stages of embryogenesis and reveal the existence of a positive cross-regulatory loop
between BMP-4 and GATA-4. They also raise the possibility that part of the early defects in GATA-4 and/or GATA-6 null embryos may
be due to impaired BMP-4 signaling.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
GATA proteins are zinc fingers, DNA-binding transcrip-
tion factors that play critical roles in cell differentiation and
embryogenesis. In vertebrates, six members of the GATA
family have been identified and subdivided into two sub-
groups, based on sequence homology and expression pat-
tern (Lowry and Atchley, 2000). The first subgroup includes
GATA-1, -2, and -3, which are present mainly in hemato-
poietic cells where they play essential nonredundant func-
tions (Weiss and Orkin, 1995). Transcripts for GATA-4, -5,
and -6 are present predominantly in cells of the heart and the
digestive system as well as in the extraembryonic endoderm
(Arceci et al., 1993; Gre´pin et al., 1994; Heikinheimo et al.,
1994; Jiang and Evans, 1996a; Laverriere et al., 1994;
Morrisey et al., 1996; White and Clark, 1993). Within these
tissues, expression of two or more GATA genes is often
detected, raising the possibility that they may have redun-
dant functions. This was further supported by the finding
that all three proteins bound to similar DNA elements on
numerous cardiac (Charron et al., 1999; Molkentin et al.,
1994; Morrisey et al., 1996; Nemer et al., 1999) and some
gastric (Gao et al., 1998; Nishi et al., 1997; Tamura et al.,
1993) promoters and potently enhanced their activity.
Moreover, ectopic expression of each gene in Xenopus
oocytes resulted in upregulation of cardiac markers (Jiang
and Evans, 1996b), while downregulation of either GATA-4
or GATA-6 proteins in cardiomyocytes similarly inhibited
several cardiac genes (Charron et al., 1999). Despite these* Corresponding author. Fax: 514-987-5575.E-mail address: nemerm@ircm.ircm.qc.ca (M. Nemer).
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Fig. 1. Specificity of the anti-GATA-4, -5, and -6 antibodies. (A) Aminoacid homology between the GATA-4, -5, and -6 proteins. Note how the C-terminal
domain is the least conserved region across the different family members. Antibodies were directed against this region. (B) Transient expression in CV-I cells
of GATA-4, -5, and -6 was detected by immunohistochemistry using the respective antibodies (G4, G5, and G6). All pictures were taken at a 20
magnification.
Fig. 2. Expression of the GATA-4 and -6 proteins during early murine development. Serial consecutive transverse sections of mice embryos at e7.5 showing
differential cellular expression of GATA-4 and GATA-6 in early embryonic and extraembryonic tissues. (A) Both proteins are expressed in precardiac
mesoderm (open arrow). Little GATA-4 is detected in the embryonic endoderm (solid arrow) and it is restricted to cells underlying the precardiac mesoderm,
whereas GATA-6 labels many more endodermal and mesodermal cells. In addition, GATA-6 is expressed in the embryonic ectoderm (*). The strongest
expression of both proteins is in the extraembryonic endoderm. Note how GATA-6 is expressed in both visceral (VE) and parietal endoderm (PE), whereas
GATA-4 is more prominent in VE. The inset is a higher magnification (40) showing labeling in blood islands (BI) and mesothelial cells (MC). (B) Other
serial sections of e7.5 embryo showing the allantois where GATA-4- and -6-positive cells are detected. Note the difference in the cells staining for GATA-4
and -6, both in the allantois and in the VE. In the low magnification (10), cells stained with the anti-GATA-6 antibody are clearly visible in the embryonic
ectoderm and mesoderm as well as in the amnion, whereas GATA-4-positive cells are restricted to the lateral plate mesoderm.
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predictions, inactivation of the GATA-4, -5, and -6 genes in
mice resulted in unique phenotypes arguing for specialized
nonredundant functions for each GATA factor. In particu-
lar, inactivation of the GATA-4 gene caused defects in
ventral morphogenesis and heart tube formation, leading to
developmental arrest between embryonic days 7 and 9.5 in
the majority of homozygous embryos, while 30–40% failed
to gastrulate (Kuo et al., 1997; Molkentin et al., 1997).
GATA-4 null embryonic stem cells were defective in vis-
ceral endoderm differentiation, suggesting an essential role
for GATA-4 in extraembryonic tissues (Narita et al., 1997;
Soudais et al., 1995). An intrinsic role for GATA-4 in heart
morphogenesis was also demonstrated in mice homozygous
for a mutation in GATA-4 that disrupts interaction with its
cofactor, FOG-2 (Crispino et al., 2001). While many cardiac
genes were shown to be activated in vitro by GATA-4, the
downstream transcription targets of GATA-4 during early
stages of embryogenesis remain largely unknown.
In addition to GATA-4, GATA-6 also appears to be
essential for visceral endoderm differentiation, and inacti-
vation of the GATA-6 gene resulted in early embryonic
lethality (e5.5– e7.5) and differentiation defects in the ec-
toderm and part of the visceral endoderm, where HNF4 was
identified as a GATA-6 target gene. The reason for the
observed apoptosis in the ectoderm remains elusive, given
that GATA-6 expression was not reported therein (Kout-
sourakis et al., 1999; Morrisey et al., 1998). In contrast,
targeted mutation of the GATA-5 gene in mice did not
interfere with embryonic or heart development, but resulted
in mild defects in female genitourinary tract (Molkentin et
al., 2000), making GATA-5 the only mammalian GATA
gene that is dispensable for embryonic development (Pan-
dolfi et al., 1995; Pevny et al., 1991; Tsai et al., 1994). This
phenotype was unexpected, given that, in zebrafish,
GATA-5 is required for survival and differentiation of myo-
cardial and endocardial precursors, and mutations in the
GATA-5 gene lead to the faust mutant characterized by
abnormal heart development (Reiter et al., 1999).
While genetic approaches in different species clearly
established the essential role of GATA factors for embry-
onic development, the molecular basis underlying their
functions and their specificity have remained unclear. In
particular, the inability of different GATA factors to com-
pensate for each other in vivo remains unexplained. It may
reflect their cross-regulation (Kuo et al., 1997; Molkentin et
al., 1997; Morrisey et al., 1998), the presence of two or
more GATA factors in common regulatory pathways (Char-
ron et al., 1999), or differential interaction with cofactors
(Durocher et al., 1997; Morin et al., 2000). Alternatively,
the proteins may not be expressed as presumed from the in
situ hybridization studies. Posttranscriptional and posttrans-
lational regulation of transcription factors is widely docu-
mented as best exemplified by the presence of caudal
mRNA throughout the embryo, whereas the protein is only
detected at the posterior end (Mlodzik and Gehring, 1987).
Other examples of posttranscriptional regulation include
alternative or defective splicing, resulting in no protein or in
isoforms with different activities or cellular localization
(Belaguli et al., 1999; Condie et al., 1990; Martin et al.,
1994; Mumberg et al., 1991). It is also possible that the
different GATA factors may be expressed in a spatially
distinct manner within the same tissue. The existence of
heterogeneity in GATA-4- and GATA-6-expressing cells is
suggested from the heterogeneous distribution of GATA-6-
positive cells in the 3.5-dpc mouse inner cell mass (Kout-
sourakis et al., 1999) and the absence of GATA-6 in P19-
derived cardiomyocyte precursors (Gre´pin et al., 1997).
Thus, precise information on cellular distribution of
GATA-4, -5, and -6 proteins and identification of down-
stream targets/effectors are prerequisite to elucidating their
mechanisms of action and their in vivo functions.
In this paper, we have analyzed the expression of the
GATA-4, -5, and -6 proteins at the single cell level by using
high-resolution immunohistochemistry with specific anti-
bodies. The results suggest that GATA-4 and GATA-6
likely play critical roles in early endoderm–mesoderm sig-
naling as revealed from their complementary expression
pattern in several extraembryonic structures closely associ-
ated with yolk sac vasculogenesis, such as the visceral
endoderm, the allantois, blood islands, and mesothelial
cells. Additionally, GATA-6 was present from the earliest
developmental stages in the ectoderm and in neuroectoder-
mal derivatives, raising the possibility that it may have a
previously unexplored function in neurogenesis. Within the
embryo, the three proteins differentially labeled several
cells of the cardiovascular and digestive systems, implicat-
ing them in the control of cardiovascular and metabolic
homeostasis. BMP-4, an activator of GATA-4 whose ex-
pression closely parallels that of GATA-4 in mesoderm
cells, was identified as a GATA-4 transcription target, sug-
gesting that, at the least, some of the early developmental
defects in the GATA-4 null embryos may be due to im-
paired BMP-4 signaling.
Materials and methods
Antibodies used
Anti-GATA-5 and anti-GATA-6 antibodies were pre-
pared as follow. cDNAs corresponding to amino acids 300–
402 of the mouse GATA-5 protein and amino acids 380–
441 of the mouse GATA-6 protein were fused to the GST
sequences in the pGEX-4T3 vector (Pharmacia 27-4583-
01). The recombinant, Coomassie blue-stained GATA-5
and GATA-6 fusion protein bands were eluted electrophori-
cally from an SDS–PAGE, emulsified with complete
Freund’s adjuvant, and injected into New Zealand white
rabbits. Another injection with incomplete Freund’s adju-
vant was given 21 and 42 days after the first injection. Two
weeks after the last injection, heart puncture was performed
on the animals and serum was collected. Immunoglobin
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purification was done by using Protein A-Sepharose CL-4B
(Pharmacia 17-0780-01). The anti-GATA-3, GATA-4,
FOG2, SRF, Nkx2.5, dHand, HNF1, and PCNA antibodies
were purchased from Santa Cruz Biotechnology (catalog
numbers, resepectively: sc-268x, sc1237x, sc-10755x, sc-
335x, sc-8697x, sc-9411x, sc8986x, and sc-56). The biotin-
ylated anti-mouse, rabbit, and goat IgGs antibodies were
purchased from Vector (catalog numbers: BA2000,
BA1000, and BA5000). The Rhodamine Avidin D and
Fluoroscein Avidin D antibodies were from Vector (catalog
numbers: A3562, A2002, and A2001). The mouse alkaline
phosphatase and Glucagon antibodies were obtained from
Sigma (A3562 and G2654), and the smooth muscle mono-
clonal antibody was from Dako (M0851). The neurofila-
ment antibody (2H3) was a kind gift from Dr. T.M. Jessell.
DNA transfections
The GATA-4, -5, and -6 entire coding sequences were
subcloned in CMV-driven expression vector (pCDNA3) as
previously described (Charron et al., 1999; Nemer et al.,
1999). CV1 cells were maintained in culture and transfected
as described previously (Gre´pin et al., 1997). For immuno-
histochemistry, 30,000 cells per well were plated in 12-well
dishes and transfected with 10 g of expression vector.
Forty-eight hours after transfection, cells were washed twice
with PBS and then fixed at room temperature for 15 min
with a 4% paraformaldehyde solution. Cells were quenched
for endogenous peroxidase activity by treating them for 5
min with 3% H2O2 and were then incubated with primary
antibodies overnight at 4°C. Cells were washed 3 times with
PBS containing 0.2% Tween, and then incubated with sec-
ondary antibodies (anti-goat peroxidase conjugate A9452
and anti-rabbit peroxidase conjugate A6154 from Sigma) at
a dilution of 1/250 for 1 h at room temperature. Revelation
was carried out by using the 3,3-Diamino-Benzidine
(DAB) chromagen (Sigma D-5637) in 0.05 M Tris, pH 7.4,
for 5 min at room temperature.
Cotransfections of GATA-expressing vectors with the
BMP-4/luc constructs were carried out as previously de-
scribed (Nemer et al., 1999). The 1.3-kbp mouse BMP-4
promoter fused to luciferase was a kind gift from Dr. H.
Stephen (Feng et al., 1995). Mutations of the GATA ele-
ments in the context of the 1.3-kpb promoter were gen-
erated by using PCR-mediated site-directed mutagenesis.
All constructs were confirmed by DNA sequencing. The
95-bp promoter was generated from the longer construct
by using SmaI. NIH3T3 cells were transfected by using the
calcium phosphate precipitation method. Briefly, 30,000
cells per well were plated on a 12-well plate. A total of 1 g
of reporter gene was used per well, and total DNA was kept
constant at 2 g. Luciferase activity was measured 36 h
after transfection by an LKB illuminometer. The results are
the mean of three independent experiments, each done in
duplicate.
GATA-4 stably transfected P19 and C2C12 cells were
generated as described previously (Gre´pin et al., 1997). Rat
neonatal cardiomyocytes were infected with an adenovirus
overexpressing GATA-4 as described in Charron et al.
(2001).
Gel shift assays
Nuclear extracts of neonatal cardiomyocytes and 293
cells transiently overexpressing GATA-4 or GATA-6 were
obtained as described previously (Charron et al., 1999).
EMSA was carried out as previously described (Gre´pin et
al., 1994) by using 3–5 g of nuclear extracts. The probe
used for GATA binding corresponded to the 232 GATA
site of the mouse BMP-4 promoter (5-GTTTCAT-
TATCTCTAATT-3).
RNA extraction and PCR analysis
Total cellular RNA was extracted according to the thio-
cyanate–phenol–chloroforme method. cDNAs were gener-
ated from 5 g of total RNA by using an oligonucleotide
dT12–18 in the presence of AMV-RT (Promega). Semiquan-
titative PCR was conducted by using specific oligonucleo-
tides for each gene, and a dose-response assay was carried
out to determine the optimal amount of cDNA to be used for
PCR amplification by using the following: 3 min at 94°C,
30 s at 94°C, 30 s annealing temperature for each oligonu-
cleotide pair, and 1 min/kb at 72°C repeated 29 cycles.
Amplification of tubulin was used as an internal control.
PCR products were resolved on 1.2% agarose gels. The
analysis was carried out in duplicate with RNA isolated
from at least two different experiments. The sequences of
the oligonucleotides for GATA-4 and tubulin were previ-
ously described (Nemer and Nemer, 2002). For BMP- 4, the
following oligonucleotides were used: forward primer, 5-
ACCTCAACTCAACCAACC-3, and reverse primer, 5-
GTGTGGTATGTGTAGGTGG-3.
Immunohistochemistry on tissue sections
Embryos were dissected from CD-1 mice (Charles Riv-
ers, Canada) at different stages of gestation and fixed over-
night with 4% paraformaldehyde solution and then embed-
ded in paraffin and sectioned 5 m thick. Rehydration was
carried out as described previously (Viger et al., 1998), and
incubation with primary antibodies was done as mentioned
above. Coupling to a biotinylated secondary antibody (bio-
tinylated anti-rabbit BA-1000 and biotinylated anti-goat
BA-5000 from Vector Laboratories) was done for 1 h at
room temperature at a dilution of 1/250 followed by three
washes in PBS, 0.2% Tween. Sections were then incubated
for 45 min at room temperature with a Streptavidin–HRP
conjugate (NEL750 from NEN Life Science) at a dilution of
1/500. Revelation was done as described above. Some sec-
tions were counterstained with Methyl-green as previously
described (Paradis et al., 2000).
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Fig. 3. GATA-4, -5, and -6 in the developing heart. Serial sagittal sections of dissected embryonic heart (A) and frontal sections (B) of embryos at e11.5.
(A) GATA-4 and GATA-5 are highly expressed in the endocardial cushions (EC). Note the high expression of GATA-5 in the endocardium and some
underlying myocardial cells. GATA-4 expression is detected both in the endocardium and myocardium. Upper panels photos are taken at 10 magnification
of the original size, while the lower panels are at 40. (B) Predominant expression of GATA-6 in the left ventricle (LV) at e11.5. Note the difference in
the number of GATA-6-stained nuclei (brown color) between left and right ventricles. Staining for dHand was used as control; dHand expression is more
intense in the right ventricle, where it is highly enriched in the endocardium. Photos are taken at 20 magnification of their original size.
Fig. 4. Expression of GATA-4 and GATA-6 during heart morphogenesis. (A) GATA-4 and GATA-6 are expressed in the bulbis cordis (BC), common atrium
(A), and sinus venosis (SV) as early as e10.5. The expression of the GATA proteins in the third branchial arch artery (3rd BA) along that of dHand and FOG2
is noteworthy. In addition, please note the expression of GATA-4 and FOG2 in the mesenchyme surrounding the lung bud (lu) and the differential distribution
of GATA-4 and GATA-6 in the liver (li). GATA-6 protein was also detected in the dorsal aorta (Ao). Magnification is 5 the original size. (B) Expression
of GATA-4, -6, and FOG2 during valvuloseptal formation. Note the strong expression of all three proteins in the outflow tract of the left ventricle leading
to the pulmonary artery (PA). GATA-6 expression follows a gradient-like pattern in the ventricles with less expression in the trabeculae compared with the
ventricular wall. Note the lower staining in the atrioventricular canal regions. GATA-4 and GATA-6 are also present in the diaphragm (d) and the liver (li),
while GATA-6 and FOG2 are coexpressed in the aorta (Ao). Magnification is 10 the original size. (C) Coexpression of GATA-4 and -6 in the e10.5 bulbis
cordis showing the nuclear staining for both. In blue, control staining for the nuclei with Hoechst, in green GATA-4, and in red GATA-6. Note how all red
nuclei (GATA-6) are also positive for GATA-4 (green). Magnification is 20 the original size.
For GATA-4/GATA-6 coimmunostaining, incubation
with the anti-GATA-4 antibody was carried out overnight
and the signal was amplified by Fluorescein Avidin D (1/
500). The anti-GATA-6 antibody was added the following
day for an incubation time of 2 h at room temperature, and
the signal was amplified by Rhodamine Avidin D (1/500).
For the GATA-4/Glucagon coimmunostaining, an anti-
mouse alkaline phosphatase antibody (1/250) was used to
detect the signal for Glucagon. Incubation with 4-Nitro Blue
Tetrazolium Chloride (NBT) and 5-Bromo-Indolyl-Phos-
phate (BCIP) (Boehringer) was carried out in the dark for 15
min to detect the blue staining.
Results
To analyze expression of the GATA-4, -5, and -6 pro-
teins at the cell level, we used immunohistochemistry with
specific antibodies directed at the C-terminal domain of
each protein. This region is the least homologous across the
different family members (Fig. 1A). Additionally, it is
present in the different GATA-5 and -6 isoforms that arise
from alternative splicing or alternative promoters and trans-
lation initiation sites (Brewer et al., 1999; MacNeill et al.,
1997). The specificity of the antibodies was ascertained by
immunohistochemistry and Western and gel shift analyses;
all were found to be highly specific and to not cross-react
with other members of the cardiac or hematopoietic GATA
factors (Fig. 1B, and data not shown).
Expression of GATA proteins in multiple extraembryonic
structures
The presence of immunoreactive GATA-4, -5, and -6
proteins was first analyzed at e7.5. At this stage, presump-
tive cardiac mesodermal cells are arranged in two bilateral
primordial structures of the lateral splanchnic mesoderm.
Staining for GATA-4, -5, and -6 was reproducibly detected
bilaterally in the lateral plate mesoderm (Fig. 2). GATA-5
and -6 immunoreactivity extended to cells in the interme-
diate mesoderm, which gives rise to urogenital organs.
Weak staining for GATA-4 was observed in a few cells of
the intermediate mesoderm. Expression of GATA-4 in the
embryonic endoderm was restricted at this stage to very few
cells underlying the presumptive cardiogenic mesoderm,
and GATA-5 was not reproducibly detected in the embry-
onic endoderm. In contrast, the GATA-6 protein was
broadly distributed at this stage in the three embryonic
layers: ectoderm, endoderm, and mesoderm, with notable
expression in the neural tube. The presence of previously
unreported GATA-6 in ectodermal cells may explain why
apoptotic cells were detected in the ectoderm of the
Gata6/ embryos, and why the ectoderm in these mice
showed abnormal development (Koutsourakis et al., 1999).
While GATA-4 and -6 were clearly detected in embry-
onic tissues, by far, the major sites of expression at this
stage were extraembryonic mesoderm and endoderm. Close
examination of serial sagital sections revealed differential
distribution with GATA-4 being highly expressed in the
visceral vs the parietal endoderm, while GATA-6 was
present in both layers (Fig. 2A). Moreover, the two proteins
were not coexpressed in all cells, suggesting cellular heter-
ogeneity (Fig. 2A and B), a finding consistent with the
reported heterogeneity for GATA-6 expression (using a
lacZ knock-in in GATA-6 heterozygote embryos) in cells of
the inner cell mass (Koutsourakis et al., 1999). Other ex-
traembryonic structures also expressed GATA-4 and -6,
including the allantois, where several cells showed positive
GATA-4 or -6 staining (Fig. 2B); these mesodermal cells
are the hemangioblasts capable of differentiating into endo-
thelial and hemopoietic cells (Caprioli et al., 2001). In
addition, there was consistent labeling of cells within the
blood islands (Fig. 2A, inset). Labeling for GATA-4 and -6
was also observed in mesothelial cells surrounding the
blood islands or lining the visceral endoderm between blood
islands (Fig. 2A); these cells are thought to give rise to
vascular smooth muscle cells of the large vitelline vessels.
A few GATA-4- and GATA-6-positive cells were also con-
sistently detected in the amnion (Fig. 2B). Together, these
findings reveal a close association of GATA-4 and -6 with
early endoderm–mesoderm signaling and yolk sac vasculo-
genesis and hemopoiesis. They also raise the intriguing
possibility that early defects in vasculogenesis and/or he-
mopoiesis may underlie the developmental arrest of
GATA-4 and/or GATA-6 null embryos.
Distinct expression of GATA-4, -5, and -6 in the
developing heart
Expression of the three GATA proteins was further ex-
amined in the developing heart starting from e8.5 just after
formation of the heart tube, which, at this stage, is com-
posed of a common atrial chamber attached to the sinus
venosus and a common ventricular chamber which is con-
tinuous to the conus at the most anterior part. At e8.5,
sagital sections of the heart showed positive staining for
GATA-4 and -6 in atrial and ventricular myocardium with
the sharpest signal at the posterior part, mainly at the junc-
tion of the atrial chamber to the sinus venosus and the
septum transversum (data not shown). Following looping,
and just prior to valvular septation of the heart, a few
myocytes—underlying the endocardium—showed positive
staining for GATA-5; however, the cells of the endocardium
and endocardial cushion were the major site of GATA-5
expression (Fig. 3, right); these cells also coexpressed
GATA-4 (Fig. 3, left). GATA-4 and -5 were also clearly
detected in pericardial cells, which are thought to contribute
to interstitial cardiac fibroblasts, coronary smooth muscle,
and endothelial cells (Mikawa and Gourdie, 1996). From
e9.5 to e12.5, GATA-4 and, to a lesser extent, GATA-6
were present in the myocardium, the endocardium, and the
endocardial cushions (Fig. 3A and B). The two proteins
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were also widely distributed in cells that will contribute to
the different heart structures, including the third branchial
arch artery, the common atria, the bulbus cordis, the sinus
venosis, and the venous valves (Fig. 4A). GATA-4 protein
was also abundantly expressed in the septum transversum,
as well as the lung mesenchyme. Expression of the GATA-
interacting protein FOG-2 (Svensson et al., 1999) was found
to colocalize with GATA-4 and -6 in the myocardium and in
the outflow tract and with GATA-6 in the aorta (Fig. 4B).
Within the myocardium, almost all GATA-6-positive myo-
cytes contained GATA-4, but a significant percent of
GATA-4-positive cells did not colabel for GATA-6 (Fig.
4C), suggesting the existence of distinct myocyte subpopu-
lations. Expression of other cardiac transcription factors,
like MEF2C, Nkx2.5, and SRF, overlapped with that of
GATA-4 and -6 only in the myocardium throughout em-
bryonic heart development (data not shown). Interestingly,
the basic helix–loop–helix transcription factor dHand
strongly labeled endocardial cells which contained GATA-4
(Fig. 3B). These findings are consistent with a role for
GATA factors in early septal and valvular development.
Extracardiac expression of GATA-4, -5, and -6
The main extracardiac sites of expression of the
GATA-4, -5, and -6 transcripts are the gonads and the
endodermal cells of the gut. We examined the cellular
distribution of all three GATA proteins in the developing
digestive and urogenital systems. As described below,
GATA-5 showed the most restricted expression in extracar-
diac tissues, being detectable only in the intestine, the blad-
der and, at low levels, in the lung. In contrast, GATA-6 was
widely distributed in organs of the digestive, urogenital, and
respiratory systems as well as in the brain. Nevertheless,
GATA-6 marked specific cells within these organs that, at
times, overlapped with GATA-4- or GATA-5-expressing
cells.
With respect to the digestive system, the three GATA
proteins were very weakly expressed at the anterior intes-
tinal port at e8 (data not shown). However, by e9.5–e10.5,
robust expression of GATA-4 and -6, but not GATA-5, was
observed in the septum transversum and the liver bud as
well as in the epithelial cells of the future hindgut (Figs. 3A
and 5A). Later, between e13.5 and e14.5, expression of
GATA-4 and -6 marked distinct cells of the developing
liver. GATA-4 was restricted to the epithelial cells lining
the liver, where it colocalized with dHand. Additionally,
scattered GATA-4-positive cells were detected within the
liver; many were lining hepatic veins and were costained
with smooth muscle actin (Fig. 5A). There was little, if any,
coexpression of GATA-4 with the hepatocyte-specific tran-
scription factor HNF1 (Nagy et al., 1994). In contrast,
GATA-6 was restricted to the hepatocytes as evidenced
from colocalization with HNF1 (Fig. 5B). GATA-5 was
never detected in the embryonic liver. GATA-4 and -6
proteins were also expressed in the developing stomach,
where they marked the gastric epithelium (Fig. 5C, and data
not shown). GATA-4 was also strongly expressed in an
anteroposterior gradient in mesenchymal cells surrounding
the junction of the stomach with the diaphragm. Later
(e17.5), GATA-4 and -6 were present in the glandular but
not in the mucosal gastric cells (Fig. 5C). GATA-6 protein
was present, though to a lower extent, in both gastric epi-
thelial and smooth muscle cells and in the esophagus (data
not shown). GATA-4 and -6 proteins were also found in the
exocrine cells of the pancreas (Fig. 5C). Finally, all three
GATA proteins were present early (beginning e11.5) in the
endodermal cells of the intestine, where their expression
pattern was partially overlapping in the epithelial cells of
the villi. GATA-6 also marked the smooth muscle cells of
the intestine (Fig. 5D). Given that the endodermal epithe-
lium contains many types of endocrine cells (Skipper and
Lewis, 2000), it will be interesting in the future to determine
whether the different GATA factors label specific hormone-
secreting cells of the gut.
In the urogenital system, the only site of GATA-5 ex-
pression was in the smooth muscle cells of the bladder (Fig.
6A) and neither the kidney, gonad, nor adrenal showed
detectable GATA-5 protein at all stages examined (e14–
e17). GATA-6, but not GATA-4, was also present in the
bladder, where it labeled both the epithelial and smooth
muscle cells (Fig. 6A). As expected (Viger et al., 1998),
GATA-4 and -6 proteins were present in the gonadal com-
ponent of the genital ridge; additionally, GATA-6 was
strongly expressed in the mesonephric component, where it
labeled the tubules (Fig. 5B). Finally, GATA-4 and -6 were
present early in adrenal cells. Cells in the adrenal cortex are
derived from the splanchnic mesoderm, whereas those of
the medulla have a neural crest origin. GATA-4 labeled
presumed adrenal cortex cells at e13.5 that were negative
for such neural crest markers as dHand and neurofilament
(Fig. 6B, left). Later (e17.5), GATA-4 became restricted to
the adrenal capsule (Fig. 6B, top right); this suggests a role
for GATA-4 in adrenal cortical cell proliferation and is
consistent with the finding of GATA-4 in murine adrenal
cortical tumors and in human adrenal cortical carcinomas,
but not in normal adult adrenal cortex (Kiiveri et al., 1999).
In contrast, GATA-6 strongly labeled cells of the medulla,
which are neural crest-derived and some cells in the cortex
(Fig. 6B). These were not the only GATA-6-expressing
neuronal cells; as mentioned earlier, GATA-6 immunoreac-
tivity was detected in the neural tube as early as e7.5 (Fig.
2), and GATA-6 positive cells persisted throughout brain
development, where GATA-6 colocalized with FOG2 in
numerous area, including the cortex and the forebrain (Fig.
6C).
Finally, the GATA-6 gene was shown to be expressed in
the lung, where it plays an essential role in branching
morphogenesis (Keijzer et al., 2001). We found that
GATA-6 was expressed in numerous pulmonary structures,
including smooth muscle cells, bronchi, mesenchyme, and
arteries (Fig. 7). These findings further extend the reported
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Fig. 5. Expression of the GATA-4, -5, and -6 proteins in the gut endoderm. (A) GATA-4 is expressed in the liver as early as e9.5 in scattered cells in the
septum transversum, the liver bud, and the epithelium of the gut (left panel, magnification 20). From e10.5 to e14.5, GATA-4 expression in the liver is
restricted to the surface epithelial cells as well as to those lining the vessels. Of note, the coexpression with dHand (magnification 20). GATA-4-expressing
cells do not colocalize with those positive for the hepatocyte marker HNF1. Some cells expressing GATA-4 colocalize with smooth muscle actin (sAc) around
the hepatic vessels. (B) The pattern of expression of GATA-6 in the liver (li) overlaps with HNF1 at e14.5. Lower magnification 10, higher magnification
40. Note expression in the gonadal ridge and the kidney. No correlation could be established between GATA-6 and PCNA (a marker of proliferation). (C)
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In the stomach, GATA-4 is expressed in the epithelial cells at e14.5, and at later stages (e17.5), becomes confined to the glandular cells (G). No expression
of GATA-4 or GATA-6 is detected in the mucosal cells (M) of the stomach at e17.5. Note the expression of both GATA-4 and GATA-6 in the embryonic
pancreas (Pan); in the adult pancreas, GATA-4 and -6 are expressed in the exocrine cells, while cells staining for Glucagon (Glu) are negative for GATA-4
(20). (D) Expression in the epithelial cells of the small intestine at e13.5 (top panel; 5) and e17.5 (middle panel, 20), and lower panel, 40. Note how
GATA-4- and -6-positive cells are almost complementary. GATA-4 and -5 have an only partially overlapping pattern.
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distribution of GATA-6 transcripts in the lung (Keijzer et
al., 2001) and reveal that GATA-6 is expressed in endoder-
mally as well as mesodermally derived pulmonary cells.
GATA-4 and -5 were also clearly detected in the lung but
were restricted to mesodermally derived cells. For example,
GATA-4 was expressed in the mesenchymal cells surround-
ing the lung bud of e11.5 embryos (Fig. 4); later (e14.5), its
expression was restricted to the pulmonary artery and veins,
where it partially overlapped with GATA-6 and SRF (Fig.
7). On the other hand, GATA-5 was restricted to the mes-
enchyme (data not shown). The absence of GATA-4 and -5
from the pulmonary endoderm may explain the dependence
on GATA-6 for lung epithelial cell differentiation (Keijzer
et al., 2001). The presence of three GATA factors in dif-
ferent cells of the lung points to the importance of this class
of regulators in pulmonary development and, possibly, dis-
eases.
The BMP-4 gene is a downstream GATA target
As stated earlier, 30–40% of GATA-4 null embryos fail
to gastrulate (Molkentin et al., 1997), and the remaining
embryos arrest around e9.5 with defects in yolk sac devel-
opment and ventral folding. Altered differentiation and/or
proliferation of mesodermal precursors or defective meso-
derm–endoderm signaling have been suggested as possible
mechanisms underlying the phenotype of GATA-4 null em-
bryos. Among the signaling molecules required for meso-
derm differentiation and gastrulation are bone morphoge-
netic proteins 2 and 4 (BMP-2 and BMP-4), which are
Fig. 6. GATA proteins in the urogenital system and in neural ectoderm. (A) GATA-4 is absent from the bladder (e17.5), whereas GATA-5 and GATA-6 are
expressed in the smooth muscle layer (black arrow). In addition, GATA-6 is expressed in the epithelial cells (open arrow) (magnification 10). (B) GATA-4
is expressed in a subset of cells of the adrenal gland at el4.5 that are distinct from those expressing dHand and neurofilament (blue color) (magnification 20).
At later stages (e17.5), GATA-4 is expressed only in the epithelium lining the adrenal, whereas GATA-6 is expressed in cells of the cortex (C) and medulla
(M) (magnification 40). (C) Expression of GATA-6 in the neural tube (NT) at e11.5 through e14.5 (magnification 20). Note the colocalization with FOG2
in the brain cortex (C) (magnification 40).
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members of the TGF superfamily of secreted peptides
(Winnier et al., 1995; Zhang and Bradley, 1996). Interest-
ingly, expression of BMP-2 and BMP-4 during early murine
development closely parallels that of GATA-4 in the ex-
tramesodermal cells of the allantois and amnion, and in the
precardiac mesoderm. We tested the possibility that BMP-4
might be a downstream target for GATA-4. The BMP-4
promoter contains two highty conserved GATA elements
(Fig. 8A) and is activated in a dose-dependent manner by
cotransfection with GATA-4 or GATA-6 expression vectors
(Fig. 8B). Both GATA elements are able to interact specif-
ically with recombinant GATA-4 and GATA-6 as well as
Fig. 7. Expression of GATA factors in multiple pulmonary cell types. Sagital consecutive sections of a mouse lung at e17.5 show that GATA-4 is expressed
in the smooth muscle cells of the pulmonary artery (PA), whereas GATA-6 and SRF are expressed in the PA, bronchi (B), and mesenchymal cells (M). All
sections were counterstained with methyl green. Magnification 10 for the left panels and 20 for the right panels.
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with endogenous GATA-4 present in cardiac extracts (Fig.
8C). In addition, binding and competition experiments in-
dicate that the distal 526-bp GATA element has a higher
affinity for GATA-4 and -6 than the 392-bp element (Fig.
8C, and data not shown). Mutation of the proximal element
in the context of the full-length BMP-4 promoter signifi-
cantly reduces GATA-dependent transactivation, whereas
mutation of either the distal element or of both GATA sites
abrogates the response to GATA-4 or GATA-6 (Fig. 8D).
Ectopic expression of GATA-4 in P19 embryonic stem
cells, in C2C12 myoblasts, or in cardiac myocytes, results in
marked induction of endogenous BMP-4 transcripts (Fig.
8E). Together, these results indicate that BMP-4 is a direct
transcription target for GATA-4 and raise the possibility
that impaired BMP-4 production and mesoderm differenti-
ation may underlie some of the early defects seen in the
GATA-4 (and possibly GATA-6) null embryos.
Discussion
In the present study, we have determined the spatial and
temporal distribution of the GATA-4, -5, and -6 proteins at
the single cell level. We also present evidence suggesting
that BMP-4 is a direct GATA-4 target. The results offer new
insight into the in vivo function of an important subfamily
of transcriptional regulators and provide an essential frame-
work for further analysis of the role of GATA-4, -5, and -6
in embryogenesis.
Amplification of the BMP-4/GATA-4 pathway through a
positive feedback loop
Previous studies have shown that BMP-4 is an activator
of GATA-4 and suggested that GATA-4 may mediate the
cardiogenic effects of BMP-4 as well as its role in hepatic
development (Schultheiss et al., 1997; Rossi et al., 2001).
The data presented here reveal that GATA-4 is a transcrip-
tional activator of BMP-4, suggesting the existence of a
positive BMP-4/GATA-4 feedback loop. This loop may
serve to amplify the BMP/GATA pathway in several em-
bryonic cell types where the two proteins and the BMP
receptors are coexpressed, notably in the extraembryonic
and embryonic mesoderm. BMP-4 and its receptors also
play key inductive roles in lung morphogenesis (reviewed in
Warburton et al., 2000); given the results of this study and
the reported requirement for GATA-6 for lung morphogen-
esis, it is tempting to speculate that altered BMP-4 signaling
may underlie the requirement of GATA-6 in lung develop-
ment.
Little is known about the transcription factors involved
in early induction of BMP-4. They include the AP-1 pro-
teins cjun and cfos (Knochel et al., 2000) and the homeobox
protein Vent2 (Onichtchouk et al., 1996). The present work
identifies GATA-4/-6 as potent regulators of the BMP-4
gene. GATA-4 activation of BMP-4 is consistent with the
reported autoactivatory effect of BMP-4 on its promoter
(Metz et al., 1998); moreover, GATA-4, whose expression
is upregulated by retinoids (Kostetskii et al., 1999; Wilson
et al., 1993), may mediate the indirect effect of retinoic acid
on BMP-4 transcription (Helvering et al., 2000). It will be
interesting in the future to test whether these or other reg-
ulators of BMP-4 converge on GATA-4 and whether GATA
proteins interact with the other transcription activators of
BMP-4.
GATA factors in extraembryonic tissues: a role in
vasculogenesis?
The finding that BMP-4 is a transcription target for
GATA-4 (and possibly GATA-6) implicates GATA-4 and
-6 in early mesoderm and endoderm signaling and yolk sac
vasculogenesis. The presence of these GATA factors in
mesoderm and endoderm suggests that they may influence
mesoderm–endoderm signaling and early vasculogesis at
several levels.
In the visceral endoderm, GATA-4 and -6 may control
expression of other growth factors that are essential for
signaling to the underlying extraembryonic mesoderm, such
as Indian Hedgehog (Ihh) and vascular endothelial growth
factor (VEGF), which are essential paracrine signals for
differentiation of the underlying extraembryonic mesoderm
into hemangioblasts and endothelial cells at the onset of
gastrulation (Belaoussoff et al., 1998; Byrd et al., 2002;
Carmeliet et al., 1996). In this respect, it is noteworthy that
a consensus high affinity GATA binding site is present in
Fig. 8. Activation of BMP-4 transcription by GATA-4 and GATA-6. (A) Schematic representation of the BMP-4 promoter. Two consensus GATA sites (in
reverse orientation) centred at positions 526 bp and 392 bp are conserved across species. (B) GATA-4 and GATA-6 activate the BMP4 promoter in a
dose response manner (25, 50, and 250 ng) when cotransfected in NIH3T3 cells. The minimal BMP-4 promoter lacking the two GATA binding sites is
unresponsive to GATA-4 or GATA-6. (C) Gel shift analysis using the two GATA elements of the BMP-4 promoter shows specific binding to endogenous
GATA-4 in cardiomyocytes nuclear extracts (blocked by the addition of the GATA-4 antibody) and to recombinant GATA-4 or GATA-6 ectopically
expressed in 293 cells. Competitor unlabeled oligonucleotides were added at 100-fold excess. S, self competitor; M, oligonucleotide containing the mutated
GATA site; C, consensus GATA binding site from the ANF promoter. Note how the526-bp probe has a higher affinity for GATA-4 than the392 element.
(D) Both GATA sites mediate GATA-dependent activation of the BMP-4 promoter. Mutation of the 392-bp (M1) or of the 526-bp (M2) GATA site in
the context of the 1300-bp promoter decreases or abolishes GATA-dependent activation. DM, mutation of both sites. Transfection conditions and DNA
concentrations are the same as in (B). The GATA-4 expression vector was used at 50 ng/well. (E) BMP-4 is a direct in vivo target for GATA-4. RT-PCR
analysis of BMP-4 transcripts in cells overexpressing GATA-4. P19 and C2C12 cells stably expressing GATA-4 show marked upregulation of BMP-4
transcripts. mRNA of rat neonatal cardiomyocytes (cardios) infected with a modified adenovirus expressing GATA-4 also show induction of BMP-4
transcripts.
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both mouse (Accession No. U41B83) and human (Acces-
sion No. AF095785) VEGF promoters, suggesting that
VEGF may indeed be a direct GATA transcription target.
Thus, the defect in visceral endoderm differentiation in
GATA-4 and -6 null embryos may translate into impaired
yolk sac vasculogenesis, leading to early embryonic lethal-
ity. Early defects in hematopoiesis or vasculogenesis may
also account for the developmental arrest in double GATA-
4/GATA-6 heterozygote mice, which die prior to e12.5
(Molkentin, 2000). Support for this hypothesis comes from
the finding that Gata4/ embryoid bodies are defective in
primitive hematopoiesis and vasculogenesis (Bielinska et
al., 1996). In fact, the pattern of expression of GATA-4 and
-6 in early embryogenesis raises the possibility for multiple
functions of these proteins in early vasculogeonesis and an
essential role in extraembryonic endoderm and mesoderm
interactions. For example, the two proteins are present in an
almost complementary manner in the allantois, which will
give rise to the umbilical blood vessels. GATA-6, and to a
lesser extent GATA-4, is also present in the blood islands,
the site of early hemangioblasts, which will differentiate
into hematopoietic and endothelial cells (Dieterlen-Lievre,
1998). Of note, GATA-6 transcripts were also detected in
the blood islands of the developing Xenopus (Gove et al.,
1997), indicating an evolutionary conserved function in
these cells. Finally, both GATA-4 and -6 were detected in
mesothelial cells lining the visceral endoderm between
blood islands, which give rise to the smooth muscle cells
that are recruited to the forming vessels. Thus, it would be
worthwhile to examine vascular and hematopoietic devel-
opment in mice lacking a Gata4 and Gata6 allele as well as
the endothelial and hematopoietic differentiation potential
of ES cells homozygous for the Gata6 gene deletion.
Finally, and in support for a role of GATA-4 and -6 in
the vasculature, it is noteworthy to point out the presence of
GATA-4 in endothelial cells of the adult heart (our unpub-
lished data) and in vascular smooth muscle cells in the
developing lung and liver (Figs. 6 and 8), as well as its
reported expression in endothelial cell progenitors derived
from mesodermal cells of e7.5 mouse embryos (Hatzopou-
los et al., 1998). Similarly, GATA-6 transcripts were also
reported in mouse endothelial progenitors (Hatzopoulos et
al., 1998) and in a human umbilical cord-derived endothe-
lial cell line in which transcriptional regulation of the en-
dothelial vascular cell adhesion molecule-1 (VCAM-1) was
dependent on GATA-6 protein (Umetani et al., 2001).
Taken together, these observations suggest a previously
unexplored role of GATA-4 and -6 in vasculogenesis and
possibly angiogenesis.
GATA factors as regulators of ectodermal cells
The high resolution of immunohistochemistry allowed
clear detection of GATA-6 in previously unreported sites.
These include the embryonic ectoderm, where dependence
on GATA-6 for proper development could help explain the
reported widespread apoptosis observed in the embryonic
ectoderm of GATA-6 null mice (Morrisey et al., 1998) as
well as abnormal ectoderm development in them (Kout-
sourakis et al., 1999). Later, GATA-6 was detected in nu-
merous ectodermal derivatives, including neural tube and
neural crest-derived cells such as adrenal medulla and motor
neurons. Thus, GATA-6 may play a previously unsuspected
role in survival and/or differentiation of the ectodermal
lineage.
Although the functions of GATA factors have been most
intensely studied in cells of the endodermal and mesodermal
lineages, accumulating evidence points to an important role
of this class of transcription factors in differentiation of
ectodermally derived cells, including neurons. The presence
of GATA-2 and -3 expression has been recently docu-
mented in the central nervous system of many species (De-
backer et al., 1999; Sheng and Stern, 1999). Moreover,
targeted mutagenesis of the Gata2 and Gata3 genes in mice
revealed an essential role for GATA-2 in the generation of
V2 interneurons and for GATA-3 in the differentiation of
the sympathetic nervous system and the cephalic neural
crest cells (Zhou et al., 2000; Lim et al., 2000). Thus,
GATA-6 is the third member of the GATA family ex-
pressed in neuronal cells. Its highly localized distribution
within the brain and in neural crest-derived cells warrants
further investigation of its regulatory role in neuronal de-
velopment.
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